Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > Market sluggish

<< Previous

Bullboard Posts

Next >>

Comment by poubelle1on Jul 29, 2017 9:51am

109 Views

Post# 26524925

RE:RE:Market sluggish

The thesis for buying this stock is that we take advantage of a strong investment cycle in infrasture spending in the US and growth through acquisition. An expansion in margins is a bonus, and possible since the base now is low.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market